北京地区多家医院2009-2012年调脂药利用分析

目的：了解北京地区医院调脂药的应用情况及变化趋势。方法：采用回顾性方法，对北京地区多家医院2009-2012年调脂药的应用品种、销售金额、用药频度、日均费用等指标进行统计、分析。结果：北京地区医院调脂药销售金额、用药频度逐年升高；最常用的是他汀类药物，其销售金额占调脂药总销售金额的约80％；用量最大的品种主要是阿托伐他汀、瑞舒伐他汀、辛伐他汀、阿昔莫司、普伐他汀。结论：他汀类调脂药是临床治疗高脂血症的一线药物，占市场主导地位，前景看好。

Analysis of the Utilization of Lipid Regulating Agents in Many Hospitals from Beijing Area during 2009- 2012

OBJECTIVE： To investigate the use and tendency of lipid regulating agents in hospitals from Beijing area. METHODS： By retrospective method, the utilization of lipid regulating agents in many hospitals from Beijing area during 2009- 2012 was analyzed statistically in respects of drug types, consumption sum, DDDs and DDC, etc. RESULTS： The consumption sum and DDDs of lipid regulating agents from Beijing area increased year by year. Stains were the most frequently used lipid regulating agents; the consumption sum of stains accounted for 80% of total consumption sum; lipid regulating agents were mainly atorvas- tatin, rosuvastatin, simvastatin, acipimox and pravastatin. CONCLUSIONS： Stains are the first-line medicine for hyperlipidemia, occupy the predominate place among lipid regulating agents and show potential in the market.